BioSpace News Archive

Glaxosmithkline to Build New Drug Testing Facility

Business

Another GSK Executive Departs as Emma Walmsley Continues to Shape Company Leadership

Changes continue at the c-suite level of GlaxoSmithKline. This week another high profile executive, Chief Financial Officer Simon Dingemans announced he will retire from GSK in 2019.

May 11, 2018

·

2 min read

·

Alex Keown

Pictured: U.S. Capitol/Courtesy Andrea Izzotti/Ado

Policy

White House Prepares to Roll Out Drug Pricing Reform Proposal Package Today

Today the president is expected to propose what could be sweeping reforms to help lower the cost of those medications for consumers.

May 11, 2018

·

3 min read

·

Alex Keown

Drug Development

FDA Advisory Committee Gives Green Light to Akcea Therapeutics Rare Disease Drug Waylivra

Akcea Therapeutics is preparing for the possible launch of its therapeutic for the treatment of the rare lipid disorder familial chylomicronemia syndrome (FCS) following the thumbs up from a U.S. Food and Drug Administration advisory committee.

May 11, 2018

·

2 min read

·

Alex Keown

Policy

Akari CEO Abruptly Resigns Following Abuse of Corporate Credit Card

For the second time in less than one year, Akari Therapeutics is without a chief executive officer. David Horn Solomon abruptly resigned after being caught using the company credit card for personal purposes.

May 11, 2018

·

2 min read

·

Alex Keown

Drug Development

AstraZeneca’s Fasenra Fails in a COPD Clinical Trial

AstraZeneca and its biologics research-and-development arm, MedImmune, indicated that its Fasenra (benralizumab) did not meet its primary endpoint in patients with moderate to very severe COPD.

May 11, 2018

·

2 min read

·

Mark Terry

Job Trends

Vyriad to Build Oncolytic Virus Manufacturing Plant in Rochester, Minnesota

Vyriad, based in Rochester, Minnesota, announced it is building out its facility in 25,000 square feet of space it is leasing on the IBM Campus in Rochester.

May 11, 2018

·

3 min read

·

Mark Terry

Gilead's $12B Bet Pays Off in Two Months After the

Business

Gilead—Down but Not Out?

You know when an analyst starts an article with, “Gilead’s Q1 financial results were a disaster,” that it requires a closer look.

May 11, 2018

·

5 min read

·

Mark Terry

Policy

Jazz Sets Aside $57M to Settle Probe into Charitable Giving as DOJ Continues to Investigate Potential Kickbacks

Jazz Pharmaceuticals set aside $57 million in the first quarter of 2018 to settle an investigation by the U.S. Attorney’s Office for the District of Massachusetts regarding its support of 501(c)(3) organizations that provide financial assistance to Medicare patients.

May 11, 2018

·

2 min read

·

Alex Keown

Business

Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results

Soligenix’s revenues for the quarter ended March 31, 2018 were $1.1 million as compared to $1.3 million for the quarter ended March 31, 2017.

May 11, 2018

·

7 min read

Job Trends

Warning Issued to Parents: Protect Your Child’s Brain and Teeth from this Dangerous Chemical Exposure

The International Academy of Oral Medicine and Toxicology is using this month to share information about fluoride’s potential to cause adverse health effects, especially in children.

May 11, 2018

·

2 min read